The Nijmegen ultra-sensitive Bethesda Assay detects very low-titer factor VIII inhibitors in patients with congenital and acquired hemophilia A

International Council for Standardization in Haematology recommendations for laboratory measurement of factor VIII and FIX type I inhibitors

(2023) Piet Meijer et al.   International Journal of Laboratory Hematology

Combining factor VIII levels and thrombin/plasmin generation: A population pharmacokinetic‐pharmacodynamic model for patients with haemophilia A

(2021) Laura H. Bukkems et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Emicizumab for the treatment of acquired hemophilia A

(2020) Paul Knoebl et al.   BLOOD

WFH Guidelines for the Management of Hemophilia, 3rd edition

(2020) Alok Srivastava et al.   HAEMOPHILIA

Pharmacodynamic monitoring of factor VIII replacement therapy in hemophilia A: Combining thrombin and plasmin generation

(2020) Lars L.F.G. Valke et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

The prospective Hemophilia Inhibitor PUP Study reveals distinct antibody signatures prior to FVIII inhibitor development

(2020) B. M. Reipert et al.   Blood Advances

Laboratory testing for factor VIII and IX inhibitors in haemophilia: A review

(2018) C. H. Miller   HAEMOPHILIA

FVIII-binding IgG modulates FVIII half-life in patients with severe and moderate hemophilia A without inhibitors

(2016) C. J. Hofbauer et al.   BLOOD

The burden of inhibitors in haemophilia patients

(2016) Christopher Walsh et al.   THROMBOSIS AND HAEMOSTASIS

Prognostic factors for remission of and survival in acquired hemophilia A (AHA): results from the GTH-AH 01/2010 study

(2014) A. Tiede et al.   BLOOD

Affinity of FVIII-specific antibodies reveals major differences between neutralizing and nonneutralizing antibodies in humans

(2014) C. J. Hofbauer et al.   BLOOD

Definitions in hemophilia: communication from the SSC of the ISTH

(2014) V. S. Blanchette et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Hemophilia A in the third millennium

(2013) Massimo Franchini et al.   BLOOD REVIEWS

Distinct characteristics of antibody responses against factor VIII in healthy individuals and in different cohorts of hemophilia A patients

(2012) S. F. J. Whelan et al.   BLOOD

Diagnosis and treatment of factor VIII and IX inhibitors in congenital haemophilia: (4th edition)

(2012) Peter W. Collins et al.   BRITISH JOURNAL OF HAEMATOLOGY

Low-titre inhibitors, undetectable by the Nijmegen assay, reduce factor VIII half-life after immune tolerance induction

(2012) M. DARDIKH et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Population pharmacokinetics of recombinant factor VIII: the relationships of pharmacokinetics to age and body weight

(2011) S. Bjorkman et al.   BLOOD